Henry Schein Q2 EPS Estimate Decreased by Leerink Partnrs

Henry Schein, Inc. (NASDAQ:HSIC) – Research analysts at Leerink Partnrs lowered their Q2 2025 earnings per share estimates for Henry Schein in a note issued to investors on Tuesday, February 25th. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings of $1.23 per share for the quarter, down from their previous estimate of $1.24. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein’s Q4 2025 earnings at $1.29 EPS, FY2025 earnings at $4.92 EPS, FY2026 earnings at $5.48 EPS and FY2027 earnings at $6.05 EPS.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.66 earnings per share.

Several other equities research analysts have also issued reports on HSIC. Jefferies Financial Group lifted their price objective on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. UBS Group dropped their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday. Wells Fargo & Company assumed coverage on Henry Schein in a research note on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target for the company. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Finally, Mizuho assumed coverage on Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target for the company. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Price Performance

NASDAQ:HSIC opened at $72.54 on Thursday. The firm has a market capitalization of $9.04 billion, a price-to-earnings ratio of 29.85, a P/E/G ratio of 2.13 and a beta of 0.91. Henry Schein has a 52-week low of $63.67 and a 52-week high of $82.63. The stock has a fifty day moving average of $74.28 and a 200 day moving average of $72.43. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Versant Capital Management Inc grew its holdings in shares of Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after acquiring an additional 335 shares during the period. Investment Management Corp VA ADV bought a new stake in shares of Henry Schein in the 4th quarter worth approximately $32,000. Venturi Wealth Management LLC boosted its position in shares of Henry Schein by 3,347.1% in the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after purchasing an additional 569 shares in the last quarter. Quent Capital LLC boosted its position in shares of Henry Schein by 91.2% in the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after purchasing an additional 323 shares in the last quarter. Finally, Smartleaf Asset Management LLC boosted its position in shares of Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after purchasing an additional 143 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.